Furthermore, it addresses the FDA’s communications With all the applicant, the retention of documents that help the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may transfer possession of an SE report to a new applicant and electronic submission of the SE report and amendments.